Skip to main content

Table 1 Demographic and clinical characteristics of patients with stages I–II and III–IV pancreatic cancer

From: Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study

Parameter

USA (2004–2013)

The Netherlands (2003–2014)

Belgium (2004–2013)

Norway (2003–2014)

Slovenia (2003–2013)

Group

Overall

Resected

Overall

Resected

Overall

Resected

Overall

Resected

Overall

Resected

Stages I–II

Number (n)

31,313

13,303 (43)

5710

2675 (47)

3437

2155 (63)

1545

526 (34)

667

406 (61)

Microscopically confirmed

27,290 (87)

13,290 (> 99)

4046 (71)

2673 (> 99)

3127 (91)

2148 (> 99)

1017 (66)

520 (99)

475 (71)

401 (99)

Gender, female

16,193 (52)

6604 (50)

2951 (52)

1268 (47)

1684 (49)

993 (46)

853 (55)

261 (50)

361 (54)

209 (52)

Age, years

70 ± 12

66 ± 11

71 ± 11

65 ± 10

69 ± 11

66 ± 10

72 ± 12

65 ± 11

69 ± 11

65 ± 10

Age group

  < 60 years

6100 (20)

3574 (27)

981 (17)

693 (26)

686 (20)

546 (25)

234 (15)

134 (26)

144 (22)

122 (30)

 60–69 years

7817 (25)

4272 (32)

1477 (26)

978 (37)

937 (27)

698 (32)

375 (24)

195 (37)

166 (25)

131 (32)

  ≥ 70 years

17,396 (56)

5457 (41)

3252 (57)

1004 (38)

1814 (53)

911 (42)

936 (61)

197 (37)

357 (54)

153 (38)

Tumor locationa

 Pancreas head

22,412 (83)

9573 (80)

4666 (89)

2187 (89)

1807 (81)

1207 (82)

851 (85)

394 (84)

471 (88)

321 (87)

 Pancreas body

2502 (9)

890 (8)

255 (5)

91 (4)

179 (8)

100 (7)

87 (9)

33 (7)

35 (7)

26 (7)

 Pancreas tail

2196 (8)

1448 (12)

296 (6)

191 (8)

244 (11)

169 (11)

62 (6)

41 (9)

32 (6)

21 (6)

 Other

4203 (13)

1392 (11)

493 (9)

206 (8)

1207 (35)

679 (32)

545 (35)

58 (11)

129 (19)

38 (9)

Differentiationb

 Well

2145 (13)

1428 (12)

283 (12)

244 (11)

389 (18)

302 (17)

61 (10)

27 (6)

41 (10)

37 (10)

 Intermediate

7574 (47)

6026 (51)

1225 (51)

1138 (52)

1072 (48)

901 (50)

352 (55)

259 (61)

153 (37)

142 (38)

 Poor/undifferentiated

6264 (39)

4464 (38)

920 (38)

802 (37)

762 (34)

608 (34)

223 (35)

135 (32)

221 (53)

192 (52)

Neoadjuvant chemotherapy

NA

50 (2)

53 (3)

NA

2 (1)

Neoadjuvant radiotherapy

522 (4)

34 (1)

20 (1)

0 (0)

1 (< 1)

Resection type

 Pancreatoduodenectomy

9479 (71)

2269 (85)

NA

NA

NA

 Distal pancreatectomy

1878 (14)

256 (10)

NA

NA

NA

 Total pancreatectomy

1629 (12)

42 (2)

NA

NA

NA

 Otherc

314 (2)

108 (4)

NA

NA

NA

Adjuvant/palliative chemotherapy

NA

NA

1392 (24)

1078 (40)

1796 (52)

1200 (56)

265 (17)

127 (24)

131 (20)

120 (30)

Adjuvant/palliative radiotherapy

4460 (14)

4193 (32)

120 (2)

33 (1)

326 (10)

190 (9)

64 (4)

17 (3)

9 (1)

8 (2)

Stages III–IV

Number (n)

55,153

1998 (4)

13,974

237 (2)

5632

298 (5)

4633

108 (2)

1997

135 (7)

Microscopically confirmed

46,973 (85)

1994 (> 99)

10,375 (74)

237 (100)

4837 (86)

297 (> 99)

3224 (70)

105 (97)

1056 (53)

124 (92)

Gender, female

26,427 (48)

969 (49)

6755 (48)

106 (45)

2700 (48)

154 (52)

2332 (50)

47 (44)

967 (48)

56 (42)

Age, years

69 ± 12

65 ± 12

68 ± 11

64 ± 10

69 ± 11

64 ± 10

71 ± 12

64 ± 10

69 ± 11

65 ± 10

Age group

  < 60 years

12,582 (23)

636 (32)

2938 (21)

69 (29)

1043 (19)

92 (31)

759 (16)

32 (30)

393 (20)

40 (30)

 60–69 years

15,081 (27)

622 (31)

4412 (32)

96 (41)

1608 (29)

103 (35)

1268 (27)

43 (40)

513 (26)

45 (33)

  ≥ 70 years

27,490 (50)

740 (37)

6624 (47)

72 (30)

2981 (53)

103 (35)

2606 (56)

26 (24)

1091 (55)

43 (32)

Tumor locationa

 Pancreas head

21,244 (56)

1069 (66)

7202 (62)

166 (79)

1585 (58)

126 (69)

1245 (63)

57 (66)

653 (64)

80 (78)

 Pancreas body

7893 (21)

168 (10)

1844 (16)

11 (5)

508 (19)

19 (10)

340 (17)

8 (9)

160 (16)

12 (12)

 Pancreas tail

9003 (24)

381 (24)

2666 (23)

34 (16)

649 (24)

37 (20)

382 (19)

21 (24)

215 (21)

10 (10)

 Other

17,013 (31)

380 (19)

2262 (16)

26 (11)

2890 (51)

116 (39)

2666 (58)

22 (20)

969 (49)

33 (24)

Differentiationd

 Well

1213 (10)

173 (11)

222 (9)

20 (11)

425 (17)

42 (17)

122 (8)

6 (7)

33 (8)

6 (7)

 Intermediate

4518 (35)

680 (45)

833 (35)

98 (51)

962 (39)

113 (47)

596 (40)

50 (61)

112 (25)

30 (34)

 Poor/undifferentiated

6795 (56)

670 (44)

1340 (56)

73 (38)

1082 (44)

88 (36)

765 (52)

26 (32)

297 (67)

52 (59)

Neoadjuvant chemotherapy

NA

15 (6)

24 (8)

NA

0 (0)

Neoadjuvant radiotherapy

139 (7)

5 (2)

9 (3)

0 (0)

0 (0)

Resection type

 Pancreatoduodenectomy

1140 (57)

178 (75)

NA

NA

NA

 Distal pancreatectomy

295 (15)

39 (17)

NA

NA

NA

 Total pancreatectomy

211 (11)

5 (2)

NA

NA

NA

 Otherc

352 (18)

15 (6)

NA

NA

NA

Adjuvant/palliative chemotherapy

NA

NA

3475 (25)

81 (34)

3661 (65)

195 (65)

1159 (25)

25 (23)

368 (18)

39 (29)

Adjuvant/palliative radiotherapy

770 (1)

383 (19)

328 (2)

7 (3)

358 (6)

35 (12)

198 (4)

4 (4)

46 (2)

5 (4)

  1. NOS not otherwise specified, NA not available; −, not applicable
  2. Enumeration data are shown as count (percentage [%]), and measurement data as mean ± standard deviation. Records are complete, otherwise specified below
  3. aThe percentages of pancreas head, body, and tail are the proportions compared to the total tumor cases of the 3 locations; ”other” includes pancreas duct, overlapping lesion, NOS, and other specified parts, and its proportion is relative to the whole cases
  4. bUnknown differentiation in stages I–II cancer: USA, overall 15,330 (49%), resected 1385 (10%); the Netherlands, overall 3282 (58%), resected 491 (18%); Belgium, overall 1214 (35%), resected 344 (16%); Norway, overall 909 (59%), resected 100 (19%); Slovenia, overall 252 (38%), resected 35 (9%); Estonia, overall 134 (47%), resected 32 (20%)
  5. cPancreatectomy (NOS) and local resection
  6. dUnknown differentiation in stages III–IV cancer: USA, overall 42,627 (77%), resected 475 (24%); the Netherlands, overall 11,579 (83%), resected 46 (19%); Belgium, overall 3163 (56%), resected 55 (19%); Norway, overall 3150 (68%), resected 26 (24%); Slovenia, overall 1555 (78%), resected 47 (35%); Estonia, overall 718 (86%), resected 5 (28%)